Clinical Trials Logo

Clinical Trial Summary

Objective: Prospectively evaluate the safety and efficacy of the Ahmed Glaucoma Drainage Device, model M4 compared with the model S2. Method: Mexican patients with Neovascular Glaucoma will be randomly included for each group (M4 and S2). They will be operated using conventional techniques and creating a sub-episcleral tunnel to place the valve's tube in the anterior chamber. They will be monitoring for one year and the results will be evaluated with respect to a postoperative reduction in pressure, changes in visual acuity, the need for drugs and complications, in addition to the demographic characteristics of each group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02260219
Study type Interventional
Source Asociación para Evitar la Ceguera en México
Contact
Status Terminated
Phase N/A
Start date January 2012
Completion date February 2013

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00491712 - Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection N/A
Recruiting NCT04519619 - Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
Completed NCT01370135 - Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma N/A
Completed NCT04970251 - Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma N/A
Completed NCT02805257 - Ahmed Glaucoma Valve Surgery With Mitomycin-C Phase 2
Recruiting NCT02067013 - Analysis of Aqueous and Vitreous Humor Phase 2
Completed NCT00524758 - Oculusgen (Ologen) Glaucoma MMC Control in Estonia Phase 3
Withdrawn NCT00727038 - Lucentis for New Onset Neovascular Glaucoma Phase 1/Phase 2
Not yet recruiting NCT02947867 - Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG Phase 2/Phase 3
Completed NCT01711879 - Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma N/A
Withdrawn NCT00441181 - Effects of Travoprost on Neovascular Glaucoma N/A
Completed NCT01051583 - Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma Phase 2
Completed NCT05156021 - A Study on the Treatment Strategy of NVG Secondary to PDR N/A
Terminated NCT01301378 - Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube N/A
Not yet recruiting NCT05316142 - Any Unique Identifier Assigned to the Protocol by the Sponsor N/A
Recruiting NCT04844619 - KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial Phase 1
Completed NCT03154892 - The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma N/A